Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Database of Interstitial Lung Diseases

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2005 by St. Antonius Hospital.
Recruitment status was  Active, not recruiting
Information provided by:
St. Antonius Hospital Identifier:
First received: December 19, 2005
Last updated: August 7, 2008
Last verified: December 2005

The cause of most interstitial lung diseases (ILDs) is still unknown. Further research, for example to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the cause of ILDs.

Interstitial Lung Diseases

Study Type: Observational
Official Title: Registration of Clinical Data and DNA/Serum of Patients With Interstitial Lung Diseases (ILD)

Resource links provided by NLM:

Further study details as provided by St. Antonius Hospital:

Estimated Enrollment: 100000
Study Start Date: January 2006
Detailed Description:

Protocol title: 'Registration of clinical data and DNA of patients with Interstitial Lung Disease (ILD)' Rationale: The etiopathogenesis of most Interstitial Lung Diseases (ILDs) is still unknown. Further research, e.g. to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the etiopathogenesis of ILDs.

Objective: Availability of relevant clinical data and DNA/serum samples of ILD patients in a database. Those data can be used for future research.

Study design: A prospective observational study

Study population: Patients diagnosed with ILD attending the pulmonology department in participating hospitals.

Intervention: a blood sample is taken from each patient. Furthermore, additional information is collected from the medical file.

Main study parameters/endpoints: DNA and serum sample, demographic variables, medical information, occupational history and hobbies.

Nature and extent of the burden and risks associated with participation, group relatedness: two tubes of blood will be drawn from the patients. The risks of drawing blood from a vein are minimal.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of an ILD, as stated by the American Thoracic Society (ATS)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00267800

St. Antonius Hospital
Nieuwegein, Netherlands, 3435CM
Utrecht, Netherlands, 3508 TG
Mesos Medisch Centrum
Utrecht, Netherlands, 3527 CE
UMC Utrecht
Utrecht, Netherlands, 3584 CX
Sponsors and Collaborators
St. Antonius Hospital
Principal Investigator: J.M.M. van den Bosch, M.D. St. Antonius Hospital
Principal Investigator: J.C. Grutters, M.D. St. Antonius Hospital
  More Information

Additional Information:
No publications provided Identifier: NCT00267800     History of Changes
Other Study ID Numbers: R05.08/A
Study First Received: December 19, 2005
Last Updated: August 7, 2008
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by St. Antonius Hospital:
Lung disease, Interstitial
Pulmonary fibrosis

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Interstitial
Respiratory Tract Diseases processed this record on February 27, 2015